Invention Grant
- Patent Title: Solid forms of an HIV capsid inhibitor
-
Application No.: US15998786Application Date: 2018-08-16
-
Publication No.: US11267799B2Publication Date: 2022-03-08
- Inventor: Bing Shi
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Fish & Richardson P.C.
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61P31/18 ; A61K45/06

Abstract:
The present disclosure relates to pharmaceutically acceptable salts, cocrystals, and crystalline forms thereof, of a compound which is N—((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2- ((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide, which is useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.
Public/Granted literature
- US20190084963A1 Solid Forms Of an HIV Capsid Inhibitor Public/Granted day:2019-03-21
Information query